ACT Genomics vs Biocartis
Biocartis
High precision diagnostics for personalized medicine
314 employees · est. 2007 · Mechelen, Belgium
Biocartis is the older company (2014 vs 2007); Biocartis is the larger of the two.
Side-by-Side Comparison
| Metric | ACT Genomics | Biocartis |
|---|---|---|
| Founded | ||
| Founded | 2014 | 2007 older |
| Headquarters | ||
| Headquarters | Taiwan | Mechelen, Belgium |
| Employees | ||
| Employees | 121 | 314 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Information Technology | Biotechnology, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Venture round | Grant |
| Total Funding | ||
| Total Funding | $20.50M | $322.90M |
| Funding Rounds | ||
| Funding Rounds | 4 | 9 |
| Taxonomy | ||
| Taxonomy | Personalized MedicineGenomic TestingPrecision MedicineCancer GenomicsBioinformaticsNGS Platform +9 | Molecular DiagnosticsPersonalized MedicineOncologyInfectious DiseasesDiagnostics TechnologyBiomolecular Analysis +7 |
| Website | ||
| Website | actgenomics.com | biocartis.com |
About ACT Genomics
ACT Genomics is a world-leading genomic test solution provider founded in 2014 and headquartered in Taiwan. The company's slogan "Make Personalized Medicine Accessible To All" reflects its commitment to providing precision medicine services globally. ACT Genomics combines tumor biology, cancer genom...
About Biocartis
Biocartis is a Belgian-based biotechnology startup founded in 2007 with a mission to revolutionize the field of molecular diagnostics. The company's slogan "High precision diagnostics for personalized medicine" encapsulates its focus on providing next generation diagnostic solutions for personalized...
Also comparing in this category
Comparing more than these two?
Get ACT Genomics, Biocartis and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does ACT Genomics compare?
A PDF of ACT Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare ACT Genomics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ACT Genomics on 12 Sep 2024, and Biocartis on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
